Detalhe da pesquisa
1.
Immunomodulatory effect of long-term oclacitinib maleate therapy in dogs with atopic dermatitis.
Vet Dermatol
; 33(2): 142-e40, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34747068
2.
Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster
Vaccines (Basel)
; 11(1)2023 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679956
3.
Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.
Vaccines (Basel)
; 11(8)2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37631877
4.
Nanoformulations with Leishmania braziliensis Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (Mesocricetus auratus) against Visceral Leishmaniasis.
Vaccines (Basel)
; 10(11)2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366357
5.
Vaccine approaches applied to controlling dog ticks.
Ticks Tick Borne Dis
; 12(3): 101631, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33494026
6.
Corrigendum: Kinetics of Phenotypic and Functional Changes in Mouse Models of Sponge Implants: Rational Selection to Optimize Protocols for Specific Biomolecules Screening Purposes.
Front Bioeng Biotechnol
; 9: 660117, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748096
7.
Amblyomma sculptum Salivary Protease Inhibitors as Potential Anti-Tick Vaccines.
Front Immunol
; 11: 611104, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33633731
8.
Historical Perspective and Biotechnological Trends to Block Arboviruses Transmission by Controlling Aedes aegypti Mosquitos Using Different Approaches.
Front Med (Lausanne)
; 7: 275, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656216
9.
Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.
PLoS One
; 15(4): e0231893, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298378
10.
Kinetics of Phenotypic and Functional Changes in Mouse Models of Sponge Implants: Rational Selection to Optimize Protocols for Specific Biomolecules Screening Purposes.
Front Bioeng Biotechnol
; 8: 538203, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33344427
11.
An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy.
Front Cell Infect Microbiol
; 9: 427, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921703
12.
Canine visceral leishmaniasis biomarkers and their employment in vaccines.
Vet Parasitol
; 271: 87-97, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303211
13.
Clinical-pathological and immunological biomarkers in dogs with atopic dermatitis.
Vet Immunol Immunopathol
; 205: 58-64, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459002
14.
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Hum Vaccin Immunother
; 12(2): 491-502, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26360663